Co-infection by Hepatitis C virus in HIV-infected patients in Southern Brazil: Genotype distribution and clinical correlates

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Wolff, Fernando H ^a,b   Fuchs, Sandra C ^a,b   Barcellos, Nêmora N T ^a,b,c   de Alencastro, Paulo Ricardo ^b,c   Ikeda, Maria Letícia R ^b,c   Brandão, Ajácio B M ^a,d   Falavigna, Maicon ^e   Fuchs, Flávio D ^a,f  

^a National Institute of Science and Technology for Health Technology Assessment (IATS) CNPq   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Hosp Sanat Partenon   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^e Centre for AIDS Studies of Rio Grande do Sul (Centro de Estudos em AIDS do Rio Grande do Sul CEARG   (Brazil)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE;

ADULT; BRAZIL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; RNA, VIRAL;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77956536459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010494     Document Type: Article

References (42)

1. UNAIDS. Global Report 2006. Avaiable at: http://data.unaids.org/pub/GlobalReport/.
2. Monteiro MR, do Nascimento MM, Passos AD, Figueiredo JF (2004) Hepatitis C: prevalence and risk factors among patients with HIV/AIDS in Belem Para, in Brazilian Amazon. Rev Soc Bras Med Trop 37(Suppl 2): 40-6.
3. Mendes-Correa MC, Barone AA, Guastini C (2001) Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop Sao Paulo 43: 15-9.
4. Pereira GA, Stefani MM, Martelli CM, Turchi MD, Siqueira EM, et al. (2006) Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil. J Med Virol 78: 719-23.
5. Pavan MH, Aoki FH, Monteiro DT, Gonçales NS, Escanhoela CA, et al. (2003) Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis 7: 253-61.
6. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, Torre-Cisneros J, García-García JA, et al. (2006) Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 20: 49-57.
7. Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, et al. (2004) Pegylated interferon alpha-2b vs standard interferon alpha-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292: 2839-48.
8. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, et al. (2004) Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351: 438-450.
9. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, et al. (2004) Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIVcoinfected persons. N Engl J Med 2004; 351: 451-9.
10. Laguno M, Murillas J, Blanco JL, Martínez E, Miquel R, et al. (2004) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 18: F27-F36.
11. Koziel MJ, Peters MG (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445-54.
12. Boom R, Sol CJ, Salimans MM, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503.
13. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, et al. (1994) A proposed system for the nomenclatute of hepatitis C viral genotypes. Hepatology 19: 1321-4.
14. Sanguinetti CJ, Dias Neto E, Simpson AJ (1994) Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17: 914-21.
15. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, et al. (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 32: 884-92.
16. Fonseca ASK, Lunge VR, Ikuta N (1999) New genotype of hepatitis C virus (HCV) in Brazil. In: XX World Congress of Pathology and Laboratory Medicine, São Paulo. pp 69-74.
17. Barcellos NT, Fuchs SC, Fuchs FD (2003) Prevalence of and risk factors for HIV infection in individuals testing for HIV at counseling centers in Brazil. Sex Transm Dis 30: 166-73.
18. Bollepalli S, Mathieson K, Bay C, Hillier A, Post J, et al. (2007) Prevalence of Risk Factors for Hepatitis C Virus in HIV-Infected and HIV/Hepatitis C Virus- Coinfected Patients. Sex Transm Dis 34: 367-70.
19. Sherman KE, Rouster SD, Chung RT, Rajicic N (2002) Hepatitis C Virus Pravalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trial Group. Clin Infec Dis 34: 831-7.
20. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, et al. (2005) Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 192: 992-1002.
21. Alter MJ (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-S9.
22. Wolff FH, Fuchs SC, Barcellos NT, Falavigna M, Cohen M, et al. (2008) Risk factors for hepatitis C virus infection in individuals infected with the HIV. Dig Liver Dis 40: 460-7.
23. Valle Tovo C, Alves de Mattos A, Ribeiro de Souza A, Ferrari de Oliveira Rigo J, Lerias de Almeida PR, et al. (2007) Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus. Liver International 27: 40-6.
24. Krug LP, Lunge VR, Ikuta N, Fonseca AS, Cheinquer H, et al. (1996) Hepatitis C virus genotypes in Southern Brazil. Braz J Med Biol Res 29: 1629-32.
25. Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, et al. (2006) Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors. Arq Gastroenterol 43: 81-84.
26. Garten RJ, Zhang J, Lai S, Liu W, Chen J, et al. (2005) Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41 (S1): S18-24.
27. Rubio Caballero M, Rubio Rivas C, Nogues Biau A, Manonelles Fernandez A (2005) Epidemiology of chronic hepatitis C virus in patients infected by human immunodeficiency virus. Study of 767 patients. Med Clin (Barc) 125: 56-8.
28. Ramos B, Nunez M, Toro C, Sheldon J, Garcia-Samaniego J, et al. (2007) Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/ HIV-coinfected patients. J Infect 54: 173-9.
29. Gonzalez SA, Liu RC, Edlin BR, Jacobson IM, Talal AH (2006) HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels. J Acquir Immune Defic Syndr 41: 582-9.
30. Zocratto KB, Caiaffa WT, Proietti FA, Carneiro-Proietti AB, Mingoti SA, et al. (2006) HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AjUDE-Brasil I Project. Cad Saude Publica 22: 839-48.
31. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, et al. (2008) EuroSIDA Study Group. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 1: 1337-44.
32. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, et al. (2004) HIV and hepatitis C coinfection within the CAESAR study. HIV Med 5: 174-9.
33. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, et al. (2006) The real-time polymerase chain reaction. Mol Aspects Med 27: 95-125.
34. Kim AY, zur Wiesch JS, Kuntzen T (2006) Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med 3: e492.
35. Schott E, Witt H, Hinrichsen H, Neumann K, Weich V, et al. (2007) Genderdependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection. J Hepatol 46: 372-80.
36. Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, et al. (2006) Acute Hepatitis C Italian Study Group. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55: 1012-9.
37. Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, et al. (2006) Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion 46: 469-75.
38. Quinn PG, Jamal MM, Carey JD, Arora S, Harris T, et al. (1999) A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia. Am J Gastroenterol 94: 668-73.
39. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G, et al. (2006) A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 13: 775-82.
40. Hyder Q, Burhan-ul-Haq M, Rashid R, Qazi S, Mehmood S, et al. (2009) Nonconventional transmission of hepatitis C: a true possibility ignored. J Pak Med Assoc 59: 430-3.
41. Zylberberg H, Thiers V, Lagorce D, Squadrito G, Leone F, et al. (1999) Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut 45: 112-6.
42. Lock G, Dirscher M, Obermeier F, Gelbmann CM, Hellerbrand C, et al. (2006) Hepatitis C-contamination of toothbrushes: myth or reality? J Viral Hep 13: 571-3.